Tag Archives: MST-188

Poloxamer 188 – helpful during a painful crisis or not?

Research involving Poloxamer 188 (also know as RheothRx or MST 188) continues to appear in the journals. The latest is some interesting work from a team working in Hungary and France published in the British Journal of Haematology (1). Poloxamer … Continue reading

Posted in drug trials, pain, red cell adhesion, sickle cell disease | Tagged , , , , | Leave a comment

Update on clinical trials in sickle cell disease

MST-188 Otherwise known as Purified Poloxamer 188, is a designated orphan drug by the US Food and Drug Administration (FDA) for trial in sickle cell disease. It is a synthetic co-polymer of polyoxyethylene (POE) and polyoxypropylene (POP) and is thought … Continue reading

Posted in drug trials, sickle cell disease | Tagged , , , , , , , | Leave a comment